Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Applied Toxicology : JAT|September 28, 2023
Dual effects of endogenous formaldehyde on the organism and drugs for its removalJiaxin Chen, Wenhui Chen, Jinjia Zhang, et al.
Cells|November 11, 2022
Nanomaterials Respond to Lysosomal Function for Tumor TreatmentXuexia Tian, Anhua Shi, Hang Yin, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|April 22, 2025
Network Pharmacology and Experimental Validation of the Effects of Shenling Baizhu San, Quzhi Ruangan Fang and Gexia Zhuyu Tang on the Intestinal Flora of Rats with NAFLDJia Guo, Anhua Shi, Yanhong Sun, et al.
Materials Today. Bio|December 20, 2021
Novel glucose-responsive nanoparticles based on p-hydroxyphenethyl anisate and 3-acrylamidophenylboronic acid reduce blood glucose and ameliorate diabetic nephropathyQiong Ma, Ligong Bian, Xi Zhao, et al.
Medwave|February 25, 2026
Global non-alcoholic fatty liver disease: analysis of the Global Burden of Disease Study (1990 to 2021)Yong Liao, Yongli Song, Sanjin Zeng, et al.
Frontiers in Microbiology|August 4, 2023
Effects of Shenling Baizhu powder on intestinal microflora metabolites and liver mitochondrial energy metabolism in nonalcoholic fatty liver miceZheng Yao, Jia Guo, Bing Du, et al.
Frontiers in Immunology|July 14, 2026
Immune crosstalk in metabolic dysfunction-associated steatotic liver disease: interactions between innate and adaptive immunityXiangqiong Li, Kunnu Jin, Jindong Fang, et al.
Colloids and Surfaces. B, Biointerfaces|January 19, 2024
Environmental stimulus-responsive mesoporous silica nanoparticles as anticancer drug delivery platformsHuanhuan Zhao, Yan Li, Jiaxin Chen, et al.
International Journal of Nanomedicine|October 22, 2019
Glucose-Sensitive Nanoparticles Based On Poly(3-Acrylamidophenylboronic Acid-Block-N-Vinylcaprolactam) For Insulin DeliveryJun-Zi Wu, Yuqing Yang, Shude Li, et al.
Frontiers in Physiology|June 29, 2026
Novel therapeutic strategies targeting mitochondrial quality control for metabolic dysfunction-associated steatotic liver diseaseHuiling Zuo, Jiaxin Chen, Yuhang Jiao, et al.
Pageof 3